NEULAND LABORATORIES
Back to Income Statement
|
NEULAND LABORATORIES Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹1,154 Cr | ₹1,096 Cr | ₹919 Cr | ₹808 Cr | ₹790 Cr |
What is the latest Total Expenditure of NEULAND LABORATORIES ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹1,154 Cr |
| Mar2024 | ₹1,096 Cr |
| Mar2023 | ₹919 Cr |
| Mar2022 | ₹808 Cr |
| Mar2021 | ₹790 Cr |
How is Total Expenditure of NEULAND LABORATORIES Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,154 Cr | 5.25 | |
| Mar2024 | ₹1,096 Cr | 19.21 | |
| Mar2023 | ₹919 Cr | 13.72 | |
| Mar2022 | ₹808 Cr | 2.32 | |
| Mar2021 | ₹790 Cr | - | |
Compare Total Expenditure of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹16,392.7 Cr | -6.2% | -3.3% | 20.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹417,028.0 Cr | 0.3% | 9% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,237.0 Cr | 1.9% | 5.9% | 12.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,801.0 Cr | 0.6% | 9.5% | 45% | Stock Analytics | |
| CIPLA | ₹108,861.0 Cr | 1.6% | 1.8% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,435.0 Cr | -1.5% | 5.7% | 14.5% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -6.2% |
-3.3% |
20.1% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses